Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 27, 2026 17:44 ET | Source: Robbins LLP

Robbins LLP Urges PHR Stockholders Who Lost Money Investing in Phreesia, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Whether Phreesia, Inc. (PHR) Misled Investors Regarding the Sustainability of Growth in its Network Solutions Business
May 26, 2026 09:00 ET | Source: Robbins LLP

Robbins LLP Reminds ZSPC Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Zspace, Inc.

Robbins LLP is Investigating Allegations that zSpace, Inc. (ZSPC) Misled Investors in Connection with its IPO
May 21, 2026 20:05 ET | Source: Robbins LLP

Robbins LLP Reminds UHG Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against United Homes Group, Inc.

Robbins LLP is Investigating Allegations that United Homes Group, Inc. (UHG) Misled Investors Regarding the Forthcoming Sale of the Company
May 21, 2026 19:12 ET | Source: Robbins LLP

Robbins LLP Encourages UPST Investors to Contact the Firm for Information About the Class Action Against Upstart Holdings, Inc.

Robbins LLP is Investigating Allegations that Upstart Holdings, Inc. (UPST) Misled Investors Regarding its Business Prospects
May 21, 2026 18:51 ET | Source: Robbins LLP

CHX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ChampionX Corporation Class Action Lawsuit

Robbins LLP is Investigating Allegations that ChampionX Corporation (CHX) Repurchased Shares of its Stock in Violation of Securities Laws
May 20, 2026 16:21 ET | Source: Robbins LLP

Robbins LLP Reminds ALDX Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Aldeyra Therapeutics, Inc.

Robbins LLP is Investigating Allegations that Aldeyra Therapeutics, Inc. (ALDX) Misled Investors Regarding its Lead Drug Candidate
May 18, 2026 18:27 ET | Source: Robbins LLP

PHR Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Phreesia, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Phreesia, Inc. (PHR) Misled Investors Regarding the Sustainability of Growth in its Network Solutions
March 20, 2026 14:50 ET | Source: Robbins LLP

IT Class Action Reminder: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Gartner, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Gartner, Inc. (IT) Misled Investors Regarding its Growth and Projected Revenue
March 20, 2026 14:15 ET | Source: Robbins LLP

ALIT Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Alight, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Alight, Inc. (ALIT) Misled Investors Regarding its Potential Growth and Financial Stability
March 17, 2026 19:26 ET | Source: Robbins LLP

TCOM Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Trip.com Group Limited Securities Class Action

Robbins LLP is Investigating Allegations that Trip.com Group Limited (TCOM) Understated the Risk of Regulatory Enforcement in light of its Monopoly